Epstein Becker Green advised a client on the sale of a home infusion provider in a high value transaction.
The firm provided comprehensive health care regulatory counsel, including regulatory diligence and managing the approval process under California’s AB 853 framework. The team coordinated closely with transaction counsel, client stakeholders, and government authorities, including the California Attorney General’s office and OHCA, and helped secure the required regulatory approvals, including a declination of review from OHCA, enabling the successful and timely closing of the transaction.
Results may vary depending on your particular facts and legal circumstances.